Home › Compare › RCPIQ vs JEPQ

RCPIQ vs JEPQ: Dividend Comparison 2026

RCPIQ yields 2000000.00% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RCPIQ wins by $4.879226400974806e+39M in total portfolio value
10 years
RCPIQ
RCPIQ
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full RCPIQ calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — RCPIQ vs JEPQ

📍 RCPIQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRCPIQJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RCPIQ + JEPQ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
RCPIQ pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RCPIQ
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, RCPIQ beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RCPIQ + JEPQ for your $10,000?

RCPIQ: 50%JEPQ: 50%
100% JEPQ50/50100% RCPIQ
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RCPIQ buys
0
JEPQ buys
0
No recent congressional trades found for RCPIQ or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRCPIQJEPQ
Forward yield2000000.00% ✓11.10%
Annual dividend / share$2.00$6.16 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.879226400974806e+39M$44.8K ✓
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓$2,152.59
Total dividends collected$4.879195005460081e+39M$16.3K ✓
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: RCPIQ vs JEPQ ($10,000, DRIP)

YearRCPIQ PortfolioRCPIQ Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$200,010,700$200,000,000.00$11,930$1,110.39+$200.00M → RCPIQ
2$3,738,731,768,458$3,738,517,757,009.35$14,133$1,224.34+$3738731.75M → RCPIQ
3$65,315,062,866,930,490$65,311,062,423,938,240.00$16,632$1,340.46+$65315062866.91M → RCPIQ
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$19,454$1,457.97+$1066400830062625.00M → RCPIQ
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$22,626$1,576.08+$16272182796453826560.00M → RCPIQ
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$26,175$1,694.09+$2.3205424011366188e+23M → RCPIQ
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$30,133$1,811.32+$3.0927990661046884e+27M → RCPIQ
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$34,531$1,927.17+$3.8524105697352695e+31M → RCPIQ
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$39,403$2,041.08+$4.484688260147987e+35M → RCPIQ
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$44,787$2,152.59+$4.879226400974806e+39M → RCPIQ

RCPIQ vs JEPQ: Complete Analysis 2026

RCPIQ — Stock

Rock Creek Pharmaceuticals, Inc., a pharmaceutical development company, focuses on the discovery, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its lead compound is Anatabine citrate, a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics, with a mechanism of action distinct from other anti-inflammatory drugs available, such as biologics, steroids, and non-steroidal anti-inflammatories. The company was formerly known as Star Scientific, Inc. and changed its name to Rock Creek Pharmaceuticals, Inc. in June 2014. Rock Creek Pharmaceuticals, Inc. is headquartered in Sarasota, Florida. On September 27, 2016, Rock Creek Pharmaceuticals, Inc., along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware.

Full RCPIQ Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this RCPIQ vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RCPIQ vs SCHDRCPIQ vs JEPIRCPIQ vs ORCPIQ vs KORCPIQ vs MAINRCPIQ vs XYLDRCPIQ vs QYLDRCPIQ vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.